The combination of PTEN deletion and 16p13.3 gain in prostate cancer provides additional prognostic information in patients treated with radical prostatectomy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The combination of PTEN deletion and 16p13.3 gain in prostate cancer provides additional prognostic information in patients treated with radical prostatectomy
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-23
DOI
10.1038/s41379-018-0107-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systemic treatments for high-risk localized prostate cancer
- (2018) Géraldine Pignot et al. Nature Reviews Urology
- Genomic Gain of 16p13.3 in Prostate Cancer Predicts Poor Clinical Outcome after Surgical Intervention
- (2017) Yogesh M. Bramhecha et al. MOLECULAR CANCER RESEARCH
- The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate Cancer
- (2016) M. Lennartz et al. CLINICAL CANCER RESEARCH
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours
- (2016) Peter A. Humphrey et al. EUROPEAN UROLOGY
- Identification of Combinatorial Genomic Abnormalities Associated with Prostate Cancer Early Recurrence
- (2016) Xiaoyu Qu et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in situ hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading
- (2016) C. G. Picanço-Albuquerque et al. VIRCHOWS ARCHIV
- Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer
- (2015) Gretchen K. Hubbard et al. CANCER RESEARCH
- The Molecular Taxonomy of Primary Prostate Cancer
- (2015) Adam Abeshouse et al. CELL
- Combined Value of Validated Clinical and Genomic Risk Stratification Tools for Predicting Prostate Cancer Mortality in a High-risk Prostatectomy Cohort
- (2015) Matthew R. Cooperberg et al. EUROPEAN UROLOGY
- Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancer
- (2015) Martina Kluth et al. INTERNATIONAL JOURNAL OF CANCER
- Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer
- (2015) Laurence Klotz et al. JOURNAL OF CLINICAL ONCOLOGY
- A multicenter study showsPTENdeletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer
- (2015) Dean A. Troyer et al. PROSTATE
- Targeting the PI3K/Akt pathway in prostate cancer: Challenges and opportunities (Review)
- (2014) PAUL TOREN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
- (2014) Emilie Lalonde et al. LANCET ONCOLOGY
- High-risk prostate cancer—classification and therapy
- (2014) Albert J. Chang et al. Nature Reviews Clinical Oncology
- Copy number alteration burden predicts prostate cancer relapse
- (2014) H. Hieronymus et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease Progression
- (2014) Khalil A. Choucair et al. Translational Oncology
- Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
- (2013) J Cuzick et al. BRITISH JOURNAL OF CANCER
- The epidemiology of high-risk prostate cancer
- (2013) Sanoj Punnen et al. CURRENT OPINION IN UROLOGY
- Multi-institutional Validation of the CAPRA-S Score to Predict Disease Recurrence and Mortality After Radical Prostatectomy
- (2013) Sanoj Punnen et al. EUROPEAN UROLOGY
- A Three-Marker FISH Panel Detects More Genetic Aberrations of AR, PTEN and TMPRSS2/ERG in Castration-Resistant or Metastatic Prostate Cancers than in Primary Prostate Tumors
- (2013) Xiaoyu Qu et al. PLoS One
- Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
- (2012) Antje Krohn et al. AMERICAN JOURNAL OF PATHOLOGY
- PTENgenomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity
- (2012) Khalil Choucair et al. BMC CANCER
- Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades
- (2012) Jonathan I. Epstein et al. EUROPEAN UROLOGY
- The CAPRA-S score
- (2011) Matthew R. Cooperberg et al. CANCER
- PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients
- (2011) T. L. Lotan et al. CLINICAL CANCER RESEARCH
- PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer
- (2010) Tarek A. Bismar et al. BJU INTERNATIONAL
- Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression
- (2009) Bo Han et al. MODERN PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started